查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589016

全球药物分析测试外包市场

Pharmaceutical Analytical Testing Outsourcing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年，全球药物分析测试外包市场预计将达到163亿美元

2023年全球药物分析测试外包市场估计为103亿美元，预计到2030年将达到163亿美元，2023年至2030年复合年增长率为6.8%。生物分析测试服务是本报告分析的细分市场之一，预计复合年增长率为 8.0%，到分析期结束时将达到 64 亿美元。分析期间分析方法开发和验证服务业的复合年增长率预计为 6.8%。

美国市场预计28亿美元，中国预计复合年增长率6.2%

预计2023年美国药品分析测试外包市场规模将达28亿美元。中国作为世界第二大经济体，预计2030年市场规模将达25亿美元，2023-2030年分析期间复合年增长率为6.2%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 6.5% 和 5.2%。在欧洲，德国预计复合年增长率为 5.3%。

全球药物分析测试外包市场－主要趋势与驱动因素总结

药品分析测试外包产业如何发展？

过去二十年来，药物分析测试外包产业经历了重大发展。主要驱动因素是药物开发、监管监督和成本效率需求日益增加的复杂性。传统上，製药公司在内部进行大部分分析测试，并管理药物开发的所有阶段，从研究和开发到市场开拓。然而，随着药品管道变得更加复杂和监管要求的增加，许多公司已转向将这些专门的测试功能外包给外部合作伙伴。这种转变使製药公司能够专注于其核心竞争力，例如药物发现和商业化，同时利用委外研发机构(CRO) 的专业知识来提供分析测试服务。

如今，外包已成为药品研发（R&D）不可或缺的一部分。药物分析测试包括原料测试、测试方法开发、稳定性测试、生物分析服务和产品放行测试等广泛的服务。透过外包这些服务，製药公司现在无需大量资本投资即可获得尖端技术、先进设备和监管专业知识。因此，外包市场呈指数级增长，CRO 提供全套服务，以满足小型生物技术公司到大型製药公司的需求。

技术进步如何形塑药物分析测试外包市场？

技术进步透过提高测试过程的准确性、效率和速度，在塑造药物分析测试外包市场方面发挥重要作用。推动该市场的最重要的技术创新之一是采用先进的分析仪器和高通量筛检技术。这些仪器，例如液相层析法质谱 (LC-MS) 和核磁共振 (NMR) 光谱，可提供更高的精度和更快的分析时间，使 CRO 能够快速、准确地处理大量样品。这些技术对于识别和量化复杂分子和杂质尤其重要，这使得它们对于药物测试至关重要。除了设备之外，自动化和机器人技术还彻底改变了实验室工作流程，提高了效率并减少了人为错误的可能性。自动化系统可以管理高度重复的任务，例如样品製备、资料收集和分析，确保结果的一致性和可重复性。这在高通量筛检和稳定性测试等需要同时处理数千个样品的领域尤其有价值。此外，云端运算和资料分析的整合使製药公司和 CRO 能够更有效地储存、共用和分析资料，简化全球团队之间的协作并确保遵守资料完整性法规。

推动药物分析测试外包的主要市场趋势是什么？

几个关键的市场趋势正在推动药物分析测试外包的成长。对生技药品和生物相似药的日益关注对先进分析测试服务的需求产生了重大影响。由于生技药品比传统的小分子药物更大、更复杂，因此需要更严格和专门的测试通讯协定来确保品质、功效和安全性。凭藉生物分析测试方面的专业知识，CRO 已成为开发这些治疗方法的製药公司的重要合作伙伴，特别是在生技药品的监管要求变得更加严格的情况下。影响市场的另一个主要趋势是加强对药物开发的监管。美国食品药物管理局(FDA) 和欧洲药品管理局(EMA) 等监管机构正在收紧药品安全、品质和功效的指导方针，製药公司正在利用其在监管合规性和高品质测试方面的专业知识。这包括测试杂质、稳定性和劣化，以及确保製造流程符合良好生产规范 (GMP)。专业和个人化药物的激增也增加了对更专业的检测服务的需求。个人化治疗，尤其是基于遗传或罕见疾病的治疗，通常需要高度专业化的分析方法，而许多製药公司可能没有能力在内部执行这些方法。因此，製药公司越来越多地将其测试需求外包给专门从事药物开发利基领域的 CRO。此外，向虚拟製药模式的转变（製药公司仅专注于药物开发并将所有其他职能外包）进一步加速了对综合分析测试服务的需求。

推动药物分析测试外包市场成长的关键因素

有多个因素推动药物分析测试外包市场的成长，每个因素都会增加对外部服务供应商的依赖。主要因素之一是药物分子的复杂性不断增加，特别是在生技药品和生物相似药领域。这些药物需要更复杂的分析测试方法来确保其安全性、纯度和功效，需要使用製药公司内部通常缺乏的高度专业化的设备和专业知识。因此，公司越来越多地将这些业务外包给拥有处理复杂生技药品测试的技术力和监管知识的 CRO。推动成长的另一个关键因素是外包为製药公司带来的成本节约潜力。透过外包分析测试，公司可以避免对昂贵的设备和基础设施进行大量资本投资，并降低与人员配备和维护内部实验室相关的成本。这对于没有资源开发内部测试能力，但需要获得高品质分析服务来开发候选药物的小型生物技术公司和新兴企业尤其有吸引力。由于製药公司面临世界各地监管机构日益严格的要求，监管压力也推动了外包需求。具有监管合规专业知识的 CRO 透过确保测试流程符合全球标准并降低核准流程中延迟和拒绝的风险来提供明显的优势。此外，药物开发全球化的趋势意味着製药公司跨多个地区业务，每个地区都有自己的监管要求。这导致人们越来越依赖具有全球企业发展和应对复杂监管环境的 CRO。最后，数位技术和资料分析的快速发展使外包成为寻求优化研发流程的製药公司的一个有吸引力的选择。凭藉先进的资料分析能力，CRO 可以深入了解试验结果、加快决策速度并提高整体药物开发效率。这些因素，加上对个人化和专业药物不断增长的需求，确保药物分析测试外包市场将继续强劲成长。

受访企业范例（共42例）

  • Bioreliance
  • Boston Analytical
  • Charles River Laboratories International, Inc.
  • Dalton Pharma Services
  • Eurofins Scientific
  • Exova
  • Halo Pharma
  • Intertek Group PLC
  • Pace Analytical Services, LLC
  • Pharmaceutical Product Development, LLC
  • SGS SA
  • Toxikon, Inc.
  • West Pharmaceutical Services, Inc.
  • WuXi AppTec, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP22502

Global Pharmaceutical Analytical Testing Outsourcing Market to Reach US$16.3 Billion by 2030

The global market for Pharmaceutical Analytical Testing Outsourcing estimated at US$10.3 Billion in the year 2023, is expected to reach US$16.3 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2023-2030. Bioanalytical Testing Service, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$6.4 Billion by the end of the analysis period. Growth in the Method Development & Validation Service segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 6.2% CAGR

The Pharmaceutical Analytical Testing Outsourcing market in the U.S. is estimated at US$2.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 6.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.5% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.

Global Pharmaceutical Analytical Testing Outsourcing Market – Key Trends & Drivers Summarized

How Has the Pharmaceutical Analytical Testing Outsourcing Industry Evolved Over Time?

The pharmaceutical analytical testing outsourcing industry has undergone a profound evolution over the past two decades, primarily driven by the increasing complexity of drug development, regulatory scrutiny, and the need for cost efficiencies. Traditionally, pharmaceutical companies conducted most of their analytical testing in-house, managing all stages of drug development from research to market entry. However, as drug pipelines have grown more complex and regulatory demands have increased, many companies have begun outsourcing these specialized testing functions to external partners. This shift allows pharmaceutical companies to focus on their core competencies, such as drug discovery and commercialization, while leveraging the expertise of contract research organizations (CROs) for analytical testing services.

Today, outsourcing has become a vital component of pharmaceutical research and development (R&D). Pharmaceutical analytical testing encompasses a wide range of services including raw material testing, method development, stability testing, bioanalytical services, and product release testing. Outsourcing these services has allowed pharmaceutical companies to access state-of-the-art technology, advanced instrumentation, and regulatory expertise without the need for significant capital investment. As a result, the outsourcing market has grown exponentially, with CROs offering a comprehensive suite of services to meet the demands of both small biotech firms and large pharmaceutical companies alike.

How Are Technological Advancements Shaping the Pharmaceutical Analytical Testing Outsourcing Market?

Technological advancements are playing a critical role in shaping the pharmaceutical analytical testing outsourcing market by improving the accuracy, efficiency, and speed of testing processes. One of the most significant innovations driving this market is the adoption of advanced analytical instruments and high-throughput screening technologies. These instruments, such as liquid chromatography-mass spectrometry (LC-MS) and nuclear magnetic resonance (NMR) spectroscopy, offer higher precision and faster analysis times, enabling CROs to handle large volumes of samples quickly and accurately. These technologies are particularly important for the identification and quantification of complex molecules and impurities, making them indispensable in pharmaceutical testing. In addition to instrumentation, automation and robotics have revolutionized laboratory workflows, allowing for greater efficiency and reducing the chances of human error. Automated systems can manage large volumes of repetitive tasks such as sample preparation, data collection, and analysis, ensuring consistent and reproducible results. This has become particularly valuable in areas like high-throughput screening and stability testing, where thousands of samples may need to be processed simultaneously. Additionally, the integration of cloud computing and data analytics has enabled pharmaceutical companies and CROs to store, share, and analyze data more efficiently, streamlining collaboration across global teams and ensuring compliance with data integrity regulations.

What Are the Key Market Trends Driving Outsourcing in Pharmaceutical Analytical Testing?

Several key market trends are driving the growth of outsourcing in pharmaceutical analytical testing. The increasing focus on biologics and biosimilars has significantly impacted the demand for advanced analytical testing services. Biologics, which are larger and more complex than traditional small-molecule drugs, require more rigorous and specialized testing protocols to ensure quality, efficacy, and safety. CROs with expertise in bioanalytical testing are becoming essential partners for pharmaceutical companies developing these therapies, especially as regulatory requirements for biologics become more stringent. Another major trend influencing the market is the rising regulatory scrutiny in drug development. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are enforcing stricter guidelines on drug safety, quality, and efficacy, prompting pharmaceutical companies to seek out CROs that can provide expertise in regulatory compliance and high-quality testing. This includes testing for impurities, stability, and degradation, as well as ensuring that manufacturing processes adhere to Good Manufacturing Practices (GMP). The increasing prevalence of specialty and personalized medicines is also driving the need for more specialized testing services. Personalized therapies, particularly those based on genetics or rare diseases, often require highly specific analytical methods, which many pharmaceutical companies may not have the in-house capability to perform. As a result, these companies are increasingly outsourcing their testing needs to CROs that specialize in niche areas of drug development. Additionally, the shift toward virtual pharma models, where companies focus exclusively on drug development and outsource all other functions, has further accelerated the demand for comprehensive analytical testing services.

Key Factors Fueling the Growth of the Pharmaceutical Analytical Testing Outsourcing Market

The growth in the pharmaceutical analytical testing outsourcing market is driven by several factors, each contributing to the increasing reliance on external service providers. One of the key drivers is the rising complexity of drug molecules, particularly in the biologics and biosimilars sector. These drugs require more sophisticated analytical testing methods to ensure their safety, purity, and efficacy, which often necessitates the use of highly specialized equipment and expertise that pharmaceutical companies may lack internally. This has prompted the outsourcing of these tasks to CROs that possess the technological capabilities and regulatory know-how to handle complex biologics testing. Another critical factor fueling growth is the cost-saving potential that outsourcing offers pharmaceutical companies. By outsourcing analytical testing, companies can avoid significant capital investment in expensive equipment and infrastructure while also reducing the costs associated with staffing and maintaining in-house laboratories. This is especially appealing to smaller biotech firms or start-ups that may lack the resources to develop in-house testing capabilities but require access to high-quality analytical services to advance their drug candidates. Regulatory pressures are also driving the demand for outsourcing, as pharmaceutical companies face increasingly stringent requirements from regulatory agencies worldwide. CROs with expertise in regulatory compliance offer a distinct advantage by ensuring that testing processes meet global standards, mitigating the risk of delays or rejections during the approval process. Additionally, the growing trend toward globalization in drug development means that pharmaceutical companies are working across multiple geographic regions, each with its own regulatory requirements. This further increases the reliance on CROs that have a global footprint and the ability to navigate complex regulatory landscapes. Lastly, the rapid advancements in digital technologies and data analytics have made outsourcing an attractive option for pharmaceutical companies looking to optimize their R&D processes. CROs that offer advanced data analytics capabilities can provide deeper insights into testing results, accelerating decision-making and improving the overall efficiency of drug development. These factors, combined with the growing demand for personalized and specialized medicines, ensure that the pharmaceutical analytical testing outsourcing market will continue to experience robust growth in the years to come.

Select Competitors (Total 42 Featured) -

  • Bioreliance
  • Boston Analytical
  • Charles River Laboratories International, Inc.
  • Dalton Pharma Services
  • Eurofins Scientific
  • Exova
  • Halo Pharma
  • Intertek Group PLC
  • Pace Analytical Services, LLC
  • Pharmaceutical Product Development, LLC
  • SGS SA
  • Toxikon, Inc.
  • West Pharmaceutical Services, Inc.
  • WuXi AppTec, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Pharmaceutical Analytical Testing Outsourcing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Complexity of Drug Development and Regulatory Compliance Drives Demand for Outsourced Pharmaceutical Analytical Testing Services
    • Increasing Stringent Regulatory Requirements from Global Health Authorities, Including FDA and EMA, Fuels Growth in Analytical Testing Outsourcing
    • Growing Focus on Cost Efficiency and Speed-to-Market in Drug Development Spurs Demand for Outsourcing Analytical Testing Services
    • Technological Advancements in Analytical Testing, Including High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry, Enhance Testing Accuracy
    • Expansion of Biologics and Biosimilars Development Strengthens Demand for Specialized Analytical Testing Outsourcing
    • Increased Adoption of Outsourcing in Emerging Markets Drives Growth of Analytical Testing Services in Asia-Pacific and Latin America
    • Rising Focus on Quality Control and Assurance in Drug Manufacturing Propels Demand for Outsourced Stability and Microbial Testing
    • Growing Need for Advanced Testing Capabilities in Pharmaceutical Packaging, Including Extractables and Leachables Testing
    • Emerging Use of Outsourced Analytical Testing for Preclinical and Clinical Trials Fuels Growth in Early-Stage Drug Development
    • Rising Demand for Analytical Testing Outsourcing in the Development of Personalized Medicine and Gene Therapies
    • Technological Innovations in Automation and AI-Powered Analytical Testing Solutions Enhance Efficiency and Data Accuracy
    • Expansion of Contract Research Organizations (CROs) Offering End-to-End Analytical Testing Services Drives Market Growth
    • Growing Use of Outsourced Analytical Testing in Generic Drug Development and Approval Processes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Bioanalytical Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 4: World 7-Year Perspective for Bioanalytical Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Method Development & Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World 7-Year Perspective for Method Development & Validation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Stability Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World 7-Year Perspective for Stability Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 10: World 7-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 11: World Pharmaceutical Analytical Testing Outsourcing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 12: USA Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 13: USA 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: Canada 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • JAPAN
    • Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 16: Japan Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 17: Japan 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • CHINA
    • Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 18: China Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 19: China 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • EUROPE
    • Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 20: Europe Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: Europe 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 22: Europe Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 23: Europe 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • FRANCE
    • Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 24: France Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 25: France 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • GERMANY
    • Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 26: Germany Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Germany 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • ITALY
    • TABLE 28: Italy Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Italy 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • UNITED KINGDOM
    • Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 30: UK Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 31: UK 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 32: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Rest of Europe 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 34: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Asia-Pacific 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 36: Rest of World Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Rest of World 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030

IV. COMPETITION